Dorothy Moore
Dr. Dorothy Moore is a Canadian infectious diseases specialist based in Montreal, Quebec.
Career and Affiliations
Canadian Paediatric Society
Moore has been a member of the Canadian Paediatric Society Infectious Diseases and Immunization Committee since 1999.1) She is also an investigator for the IMPACT program, which is funded by the Centre for Immunization and Respiratory Infectious Diseases at the Public Health Agency of Canada, with additional funding for surveillance for rotavirus and invasive meningococcal disease provided by GlaxoSmithKline, Merck, Novartis and Pfizer.2)
Moore authored Your Child’s Best Shot: A parent’s guide to vaccination.3)
Montreal Children's Hospital
Moore is an infectious diseases specialist at the Montreal Children's Hospital.4)
McGill University
Moore is an associate professor of paediatrics at McGill University with an interest in health-care associated infections, influenza and paediatric HIV.
Public Health Agency of Canada
Moore is a liaison representative for the Canadian Paediatric Society (CPS) on the National Advisory Committee on Immunization (NACI), responsible for approving COVID-19 vaccines in Canada.5)
Research
Moore has published research alongside Theresa Tam on influenza and influenza vaccines.6) She has received funding from GlaxoSmithKline.7)
1)
Department Acknowledgement - Dorothy Moore. (2019, October 18). McGill University. https://web.archive.org/web/20220422062742/https://www.mcgill.ca/peds/files/peds/20191018_-_dorothy_moore.pdf
2)
Public Health Agency of Canada (2022-02-25). National Advisory Committee on Immunization (NACI): Membership and representation. Government of Canada. Archived from the original on 2022-03-23. Retrieved 2022-03-29.
3)
Your Child’s Best Shot: A parent’s guide to vaccination, 4th edition. CPS Bookstore. Retrieved April 21, 2022, from https://bookstore.cps.ca/stock/details/your-childs-best-shot-a-parents-guide-to-vaccination-4th-edition
4)
CPS awards recognize outstanding contributions to child and youth health. (2015, May 19). Canadian Paediatric Society. https://archive.ph/IpRZD
5)
National Advisory Committee on Immunization (NACI): Membership and representation. (2020, December 18). Wayback Machine; Government of Canada. https://web.archive.org/web/20201218222110/https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/naci-membership-representation.html
6)
Moore, D. L., Vaudry, W., Scheifele, D. W., Halperin, S. A., DéryP., Ford-Jones, E., Arishi, H. M., Law, B. J., Lebel, M., Le Saux, N., Grimsrud, K., & Tam, T. (2006). Surveillance for Influenza Admissions Among Children Hospitalized in Canadian Immunization Monitoring Program Active Centers, 2003–2004. Pediatrics, 118(3), e610–e619. https://doi.org/10.1542/peds.2005-2744
7)
Tran, D., Vaudry, W., Moore, D., Bettinger, J. A., Halperin, S. A., Scheifele, D. W., Jadvji, T., Lee, L., & Mersereau, T. (2016). Hospitalization for Influenza A Versus B. PEDIATRICS, 138(3), e20154643–e20154643. https://doi.org/10.1542/peds.2015-4643